Jovan Malinić
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jovan Malinić has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Ilić
A Clinic for Eye Diseases, Clinical Center of Serbia , Belgrade , Serbia
1 shared publication - Aleksandra Radosavljevic
University of Belgrade
1 shared publication - Bojana Dacic-Krnjaja
Clinic for Eye Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia
1 shared publication Darko Mihaljica
Group for Medical Entomology, Centre of Excellence for Food and Vector-Borne Zoonoses, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia
1 shared publication- Gorana Veinović
Group for Medical Entomology, Centre of Excellence for Food and Vector-Borne Zoonoses, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11102 Belgrade, Serbia
1 shared publication - Jasmina Poluga
Clinic for Infectious and Tropical Diseases, University Clinical Center of Serbia, Bulevar oslobođenja 16, 11000 Belgrade, Serbia
1 shared publication
Latest Publications
- Open Access
- 29 April 2025
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 19 (04) , 630-635
Isolation and cultivation of Borrelia lusitaniae from the blood of a patient with multiple erythema migrans
Introduction: The region of Serbia is characterised by a high prevalence and diversity of Borrelia species, with Borrelia lusitaniae dominating, followed by Borrelia afzelii. Before this report, there were no data on Borrelia species causing Lyme borreliosis (LB) in Serbia. Case presentation: We report the case of a 10-year-old boy with a clinical presentation of disseminated erythema migrans (EM). His results showed IgM antibodies at 6.27 (negative ˂ 0.20; positive ˃ 0.32) against Borrelia burgdorferi sensu lato, which was confirmed via ELFA. Except for skin lesions, the patient did not show any other clinical signs of systemic infection. His blood was taken to isolate and cultivate spirochetes and for molecular analysis. Antimicrobial therapy was prescribed according to the recommended treatment for patients with LB. A follow-up examination was conducted after nine days. The EMs on the skin had disappeared, and antibiotic therapy was continued for 14 days. A second follow-up was conducted one month after the end of therapy. The boy's health condition was normal. After 16 days of incubation in BSK-H medium, viable, motile, and spiral-shaped spirochetes were observed in the culture tube, and cultivation was prolonged for 29 days. PCR and sequencing were successful in both the blood sample and the culture and confirmed the presence of B. lusitaniae. Conclusions: The results presented here is the first Borrelia isolate from the blood of a patient with the clinical manifestation of LB-disseminated EM. The presented results confirm the potential of B. lusitaniae for dissemination via the hematogenous route.
- 29 April 2025
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 19 (04) , 630-635
Open AccessIsolation and cultivation of Borrelia lusitaniae from the blood of a patient with multiple erythema migrans
Introduction: The region of Serbia is characterised by a high prevalence and diversity of Borrelia species, with Borrelia lusitaniae dominating, followed by Borrelia afzelii. Before this report, there were no data on Borrelia species causing Lyme borreliosis (LB) in Serbia. Case presentation: We report the case of a 10-year-old boy with a clinical presentation of disseminated erythema migrans (EM). His results showed IgM antibodies at 6.27 (negative ˂ 0.20; positive ˃ 0.32) against Borrelia burgdorferi sensu lato, which was confirmed via ELFA. Except for skin lesions, the patient did not show any other clinical signs of systemic infection. His blood was taken to isolate and cultivate spirochetes and for molecular analysis. Antimicrobial therapy was prescribed according to the recommended treatment for patients with LB. A follow-up examination was conducted after nine days. The EMs on the skin had disappeared, and antibiotic therapy was continued for 14 days. A second follow-up was conducted one month after the end of therapy. The boy's health condition was normal. After 16 days of incubation in BSK-H medium, viable, motile, and spiral-shaped spirochetes were observed in the culture tube, and cultivation was prolonged for 29 days. PCR and sequencing were successful in both the blood sample and the culture and confirmed the presence of B. lusitaniae. Conclusions: The results presented here is the first Borrelia isolate from the blood of a patient with the clinical manifestation of LB-disseminated EM. The presented results confirm the potential of B. lusitaniae for dissemination via the hematogenous route.
- Open Access
- 1 January 2024
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Medicinska istrazivanja
- Vol. 57 (4) , 77-85
Inflammatory manifestations of Herpesviridae infection in the anterior segment of the eye
Introduction: Herpesviridae is a large family of double-stranded DNA viruses with eight types known to infect humans: Herpes simplex virus (HSV) type 1 and 2, Varicella zoster virus (VZV), Cytomegalovirus (CMV), Epstein Barr virus (EBV), Human herpesvirus (HHV) 6, 7 and 8. Herpetic eye disease can affect the anterior and/or posterior segment of the eye. In this article we focused on the anterior segment manifestations. Methods: A review of research articles with key words scleritis, keratitis, anterior uveitis, herpetic, HSV, VZV, CMV, and EBV published in PubMed database until April 30th, 2024 was done. Results: HSV1, VZV, and CMV are well known to cause inflammation in the anterior segment of the eye, which includes episcleritis, scleritis, keratitis, and anterior uveitis or their combination. However, there are reports of anterior segment inflammation caused by EBV, HSV2, or HHV6. The disease usually has a recurrent or chronic course and persistent inflammation can cause severe damage to the ocular tissues, which can significantly impair vision. Although some types of ocular inflammation can be effectively treated with antiviral agents during active phase of the disease (HSV1, HSV2, VZV, CMV), so far there is no final treatment which would permanently prevent the recurrences. The main complications include corneal scarring, scleral thinning, glaucoma, synechiae, iris atrophy, and cataract. Conclusion: Due to its recurrent or chronic course, the herpetic inflammation of the anterior segment of the eye remains a challenge for clinicians. While typical clinical clues may sometimes lead an ophthalmologist to suspect a herpetic cause of the inflammation, a definitive diagnosis-especially in atypical cases-can only be confirmed by PCR verification of the viral genome from ocular tissues or, in cases of uveitis, by detecting local specific antibody production in the aqueous humor using the Goldmann-Witmer coefficient.
- 1 January 2024
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Medicinska istrazivanja
- Vol. 57 (4) , 77-85
Open AccessInflammatory manifestations of Herpesviridae infection in the anterior segment of the eye
Introduction: Herpesviridae is a large family of double-stranded DNA viruses with eight types known to infect humans: Herpes simplex virus (HSV) type 1 and 2, Varicella zoster virus (VZV), Cytomegalovirus (CMV), Epstein Barr virus (EBV), Human herpesvirus (HHV) 6, 7 and 8. Herpetic eye disease can affect the anterior and/or posterior segment of the eye. In this article we focused on the anterior segment manifestations. Methods: A review of research articles with key words scleritis, keratitis, anterior uveitis, herpetic, HSV, VZV, CMV, and EBV published in PubMed database until April 30th, 2024 was done. Results: HSV1, VZV, and CMV are well known to cause inflammation in the anterior segment of the eye, which includes episcleritis, scleritis, keratitis, and anterior uveitis or their combination. However, there are reports of anterior segment inflammation caused by EBV, HSV2, or HHV6. The disease usually has a recurrent or chronic course and persistent inflammation can cause severe damage to the ocular tissues, which can significantly impair vision. Although some types of ocular inflammation can be effectively treated with antiviral agents during active phase of the disease (HSV1, HSV2, VZV, CMV), so far there is no final treatment which would permanently prevent the recurrences. The main complications include corneal scarring, scleral thinning, glaucoma, synechiae, iris atrophy, and cataract. Conclusion: Due to its recurrent or chronic course, the herpetic inflammation of the anterior segment of the eye remains a challenge for clinicians. While typical clinical clues may sometimes lead an ophthalmologist to suspect a herpetic cause of the inflammation, a definitive diagnosis-especially in atypical cases-can only be confirmed by PCR verification of the viral genome from ocular tissues or, in cases of uveitis, by detecting local specific antibody production in the aqueous humor using the Goldmann-Witmer coefficient.